University of Chicago Medicine researchers said they saw “rapid recoveries” in 125 COVID-19 patients taking Gilead Sciences Inc.’s experimental drug remdesivir as part of a clinical trial, according to a Thursday afternoon report. Shares of Gilead Sciences Inc. GILD, +2.55% jumped 12.7% in after-hours trading on Thursday following the publication …
Read More »Gilead drug produced ‘rapid’ recovery in coronavirus patients, report says
